Humacyte (HUMA) Change in Inventory (2025 - 2026)
Humacyte's (HUMA) quarterly Change in Inventory came in at -$2.3 million in Q2 2026, down 176.87% year-over-year from $2.9 million in Q2 2025, and down 10.92% quarter-over-quarter from -$2.0 million in Q1 2026.
Powered by 
Analysis
Humacyte (HUMA) Change in Inventory (2025 - 2026) Analysis & Trends
Humacyte (HUMA) has reported Change in Inventory for 2 consecutive years, with -$2.3 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Change in Inventory fell 176.87% year-over-year to -$2.3 million in Q2 2026; TTM through Jun 2026 was $6.6 million, a 40.28% decrease from a year earlier, with the FY2025 full-year figure at $21.8 million, changed N/A from the prior year.
- Change in Inventory was -$2.3 million for Q2 2026 at Humacyte, down from -$2.0 million in the prior quarter.
- Over five years, Change in Inventory peaked at $8.0 million in Q1 2025 and troughed at -$2.3 million in Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.21 Bn | 9.36 Bn | 112.79 Mn | 958,000.00 |
| 2 | CRISPR Therapeutics AG | 5.02 Bn | 5.02 Bn | - | - |
| 3 | Iovance Biotherapeutics | 3.64 Bn | 3.34 Bn | 55.72 Mn | 177,000.00 |
| 4 | Legend Biotech | 3.53 Bn | 2.57 Bn | 251.50 Mn | -6.00 Mn |
| 5 | uniQure | 2.98 Bn | 2.98 Bn | 5.49 Mn | - |
| 6 | Beam Therapeutics | 2.53 Bn | 2.53 Bn | - | - |
| 7 | Precigen | 2.39 Bn | 2.39 Bn | 52.17 Mn | 5.79 Mn |
| 8 | Sarepta Therapeutics | 2.15 Bn | 1.35 Bn | 251.87 Mn | -39.91 Mn |
| 9 | Vericel | 1.93 Bn | 1.76 Bn | 56.40 Mn | 183,000.00 |
| 10 | Humacyte | 133.72 Mn | 133.72 Mn | -825,000.00 | -2.27 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2.27 Mn |
| Mar 31, 2026 | -2.04 Mn |
| Dec 31, 2025 | 3.56 Mn |
| Sep 30, 2025 | 7.30 Mn |
| Jun 30, 2025 | 2.95 Mn |
| Mar 31, 2025 | 8.02 Mn |